Fate Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| REDMILE GROUP, LLC | 11/14/2025 | 12.87 M | $16.22 M | 0.00% | 10.86% |
| BLACKROCK, INC. | 11/12/2025 | 10.68 M | $13.46 M | -1.20% | 9.01% |
| VANGUARD GROUP INC | 11/07/2025 | 8.80 M | $11.09 M | 0.36% | 7.42% |
| WILSHIRE ADVISORS LLC | 11/14/2025 | 8.49 M | $10.69 M | 100.00% | 7.16% |
| JOHNSON & JOHNSON | 11/13/2025 | 3.38 M | $4.26 M | 0.00% | 2.85% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 2.71 M | $3.41 M | 10.17% | 2.29% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.53 M | $3.19 M | 4.16% | 2.13% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 2.52 M | $3.17 M | 0.00% | 2.12% |
| STATE STREET CORP | 11/14/2025 | 2.42 M | $3.05 M | 8.43% | 2.04% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 2.09 M | $2.64 M | -14.06% | 1.77% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.87 M | $2.35 M | 0.00% | 1.58% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.49 M | $1.87 M | -40.82% | 1.25% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 1.26 M | $1.59 M | 488.69% | 1.07% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.13 M | $1.43 M | 33.70% | 0.95% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 1.01 M | $1.27 M | 104.30% | 0.85% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 963.87 K | $1.21 M | 9.57% | 0.81% |
| MORGAN STANLEY | 11/14/2025 | 929.94 K | $1.17 M | -61.79% | 0.78% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 900.76 K | $1.13 M | 294.37% | 0.76% |
| CITADEL ADVISORS LLC | 11/14/2025 | 824.55 K | $1.04 M | -81.85% | 0.70% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/17/2025 | 814.64 K | $1.03 M | -32.88% | 0.69% |
| NORTHERN TRUST CORP | 11/14/2025 | 814.47 K | $1.03 M | -3.54% | 0.69% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 785.92 K | $990.26 K | 7.09% | 0.66% |
| MONACO ASSET MANAGEMENT SAM | 11/10/2025 | 770.00 K | $970.20 K | 14.07% | 0.65% |
| BRUCE & CO., INC. | 11/13/2025 | 729.19 K | $918.78 K | 69.90% | 0.62% |
| WOODLINE PARTNERS LP | 11/14/2025 | 712.65 K | $897.94 K | 0.00% | 0.60% |
| JANE STREET GROUP, LLC | 11/14/2025 | 603.76 K | $760.74 K | 29.61% | 0.51% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 544.59 K | $686.18 K | -41.49% | 0.46% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 469.07 K | $591.03 K | 447.77% | 0.40% |
| XTX TOPCO LTD | 11/14/2025 | 437.92 K | $551.78 K | 1.29% | 0.37% |
| QUADRATURE CAPITAL LTD | 11/13/2025 | 377.36 K | $475.47 K | 100.00% | 0.32% |
| KNOTT DAVID M JR | 11/12/2025 | 365.00 K | $459.90 K | 100.00% | 0.31% |
| NUVEEN, LLC | 11/12/2025 | 336.87 K | $424.46 K | 0.00% | 0.28% |
| PRIVIUM FUND MANAGEMENT B.V. | 11/04/2025 | 333.22 K | $419.86 K | 199.95% | 0.28% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 316.34 K | $398.58 K | 8.84% | 0.27% |
| INVESCO LTD. | 11/13/2025 | 314.83 K | $396.68 K | 23.28% | 0.27% |
| UBS GROUP AG | 11/13/2025 | 314.76 K | $396.60 K | -67.30% | 0.27% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 310.83 K | $392.00 K | 21.07% | 0.26% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 261.67 K | $329.71 K | -22.97% | 0.22% |
| MAN GROUP PLC | 11/14/2025 | 219.66 K | $276.77 K | 100.00% | 0.19% |
| BARCLAYS PLC | 11/12/2025 | 210.49 K | $265.21 K | -53.54% | 0.18% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 187.70 K | $236.50 K | 0.00% | 0.16% |
| ROYAL BANK OF CANADA | 11/14/2025 | 187.34 K | $236.00 K | 24.93% | 0.16% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 178.93 K | $225.45 K | -38.14% | 0.15% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 157.16 K | $198.02 K | 100.00% | 0.13% |
| RHUMBLINE ADVISERS | 11/06/2025 | 154.09 K | $194.14 K | -1.14% | 0.13% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 146.55 K | $184.66 K | 20.00% | 0.12% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 145.84 K | $183.76 K | -31.32% | 0.12% |
| IEQ CAPITAL, LLC | 11/14/2025 | 137.56 K | $173.33 K | 17.52% | 0.12% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 133.84 K | $168.64 K | 9.53% | 0.11% |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 11/14/2025 | 113.66 K | $143.21 K | 0.00% | 0.10% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Fate Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 218 institutional investors and hedge funds held shares of Fate Therapeutics, Inc.. The most heavily invested institutionals were:
Redmile Group, LLC: 12.87 M
BlackRock, Inc.: 10.68 M
VANGUARD GROUP INC: 8.8 M
Wilshire Advisors LLC: 8.49 M
JOHNSON & JOHNSON: 3.38 M
ACADIAN ASSET MANAGEMENT LLC: 2.71 M
67.91% of Fate Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 104.45 M shares in the last 24 months. This purchase volume represents approximately $126.38 M in transactions.